Polyol derivatives, processes for preparing the same and their uses in therapeutics
AssigneeSanofi
InventorsMichel Chignac, Claude Grain, Fernand Jammot, Charles Pigerol, Pierre Eymard, Bernard Ferrandes
Life of this patent
Estimating the term…
Loading patent…
AssigneeSanofi
InventorsMichel Chignac, Claude Grain, Fernand Jammot, Charles Pigerol, Pierre Eymard, Bernard Ferrandes
Estimating the term…
Mono-, di-, tri- and tetra-esters derived from an acid of the general formula: R--OH in which R represents an acyl radical of the general formula: ##STR1## in which n represents 0 or 1, m represents 0, 1, 2, 3 or 4, R.sub.1 and R.sub.2 each represent a straight- or branched-chain alkyl radical having from 1 to 5 carbon atoms, R.sub.3 represents hydrogen or a straight- or branched-chain alkyl radical having from 1 to 5 carbon atoms, the sum of the carbon atoms in R.sub.1 and R.sub.2 being from 4 to 10 when R.sub.3 represents hydrogen and the sum of the carbon atoms in R.sub.1, R.sub.2 and R.sub.3 being from 6 to 15 when R.sub.3 is different from hydrogen, or R.sub.1 and R.sub.2 when they are taken together represent a tetramethylene, pentamethylene or hexamethylene radical and R.sub.3 represents a straight-chain alkyl radical and an alcohol selected from the group consisting of glycerol, 2,3-epoxy-propanol, 1,2-propanediol, 1,3-propanediol, 1,2-butanediol, 1,3-butanediol, 1,4-butanediol, 1,2,3-butanetriol, 1,2,4-butanetriol, 1,2,3,4-butanetetrol, 2-buten-1,4-diol, 2-butyn-1,4-diol, diethyleneglycol, a cyclohexanediol preferably 1,2-cyclohexanediol, thiodiglycol, diethanolamine, N-R-substituted-diethanolamine, trimethylolpropane, pentaerythritol and an alcohol of the general formula: ##STR2## in which p represents 0 or 1, R.sub.4 represents methyl, R.sub.5 represents methyl, ethyl, 2-methyl-butyl or R.sub.4 and R.sub.5, when they are taken together represent a pentamethylene radical, with the exception of glyceryl tri-(di-n-propylacetate). These esters are useful in the treatment of central nervous system disorders and including, in particular, convulsive states and seizures, and disorders relating to the field of neuropsychiatry.
A pharmaceutical or veterinary composition for treating anoxia, convulsive states and seizures, which comprises as essential active ingredient at least one glyceryl ester selected from the group consisting of glyceryl 1,2-bis-(di-n-propylacetate) and glyceryl 1,3-bis-(di-n-propylacetate), in combination with a pharmaceutical carrier or excipient therefor, in dosage unit form containing 50 to 600 mg. of active ingredient.
A method of treating anoxia, convulsive states and seizures in a human being in need of such treatment, which comprises administering to said human being an effective dose of from 10 mg/kg to 50 mg/kg of a glyceryl ester selected from the group consisting of glyceryl 1,2-bis-(di-n-propylacetate) and glyceryl 1,3-bis-(di-n-propylacetate).
Dependencies are inferred from the claim text.